BlackRock Investment Management’s MasTec MTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$9.33M Sell
243,833
-1,014
-0.4% -$34.4K 0.01% 1162
2016
Q3
$7.28M Sell
244,847
-2,921
-1% -$80.1K 0.01% 1228
2016
Q2
$5.53M Sell
247,768
-5,695
-2% -$126K 0.01% 1363
2016
Q1
$5.13M Buy
253,463
+5,947
+2% +$97.3K 0.01% 1362
2015
Q4
$4.3M Sell
247,516
-504
-0.2% -$8.96K 0.01% 1488
2015
Q3
$3.93M Buy
248,020
+2,237
+0.9% +$39K 0.01% 1549
2015
Q2
$4.88M Buy
245,783
+63,907
+35% +$1.19M 0.01% 1516
2015
Q1
$3.51M Buy
181,876
+3,192
+2% +$63.8K ﹤0.01% 1640
2014
Q4
$4.04M Sell
178,684
-1,599
-0.9% -$39.5K 0.01% 1524
2014
Q3
$5.52M Buy
180,283
+11,158
+7% +$332K 0.01% 1268
2014
Q2
$5.21M Buy
169,125
+4,973
+3% +$187K 0.01% 1357
2014
Q1
$7.13M Buy
164,152
+729
+0.4% +$27.7K 0.01% 1122
2013
Q4
$5.35M Sell
163,423
-4,875
-3% -$154K 0.01% 1298
2013
Q3
$5.1M Buy
168,298
+11,109
+7% +$365K 0.01% 1285
2013
Q2
$5.17M Buy
+157,189
New +$4.74M 0.01% 1188

Other funds holding MTZ

BlackRock Investment Management's MTZ Position: Q4 2016 in Review

BlackRock Investment Management reduced its MasTec (MTZ) stake by 0.41% in Q4 2016, selling an estimated $34.4K and leaving 243,833 shares worth $9.33M. The position accounts for 0.01% of the portfolio, ranked #1162.

BlackRock Investment Management first reported a position in MTZ in Q2 2013 and has held it in 15 quarters since. 239 funds tracked by Wall St. Rank hold MTZ as of Q4 2016.

  • BlackRock Investment Management held 243,833 shares of MasTec worth $9.33M as of Q4 2016.
  • BlackRock Investment Management sold 1,014 MasTec shares in Q4 2016, an estimated $34.4K.
  • MasTec made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1162 holding.
  • BlackRock Investment Management first reported a position in MasTec in Q2 2013 and has held it in 15 quarters since.
  • 239 funds tracked by Wall St. Rank held MasTec as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.